Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 339 publications

Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists.

Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists.

Journal: Current opinion in oncology
Published: October 01, 2025

GnRH Antagonists: Current Evidence and Role in Prostate Cancer.

GnRH Antagonists: Current Evidence and Role in Prostate Cancer.

Journal: Archivos espanoles de urologia
Published: August 08, 2025

Adverse Cardiovascular Outcomes of Individuals Treated with Androgen Deprivation Therapy.

Adverse Cardiovascular Outcomes of Individuals Treated with Androgen Deprivation Therapy.

Journal: Urology practice
Published: July 18, 2025

A Case of Triplet Therapy Showing Remarkable Efficacy for Multiorgan Metastatic Recurrence After Radical Prostatectomy in Prostate Cancer.

A Case of Triplet Therapy Showing Remarkable Efficacy for Multiorgan Metastatic Recurrence After Radical Prostatectomy in Prostate Cancer.

Journal: IJU case reports
Published: June 16, 2025

Patients' Preferences and the Time to Finish Gonadotropin-Releasing Hormone (GnRH) Agonist and Antagonist Injections in Japanese Prostate Cancer Patients.

Patients' Preferences and the Time to Finish Gonadotropin-Releasing Hormone (GnRH) Agonist and Antagonist Injections in Japanese Prostate Cancer Patients.

Journal: Cureus
Published: May 27, 2025

Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US.

Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US.

Journal: Future oncology (London, England)
Published: April 07, 2025

Exploration of cardiac adverse events associated with relugolix and degarelix: a multi-center pharmacovigilance study based on the FAERS database.

Exploration of cardiac adverse events associated with relugolix and degarelix: a multi-center pharmacovigilance study based on the FAERS database.

Journal: Expert opinion on drug safety
Published: April 03, 2025

GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy.

GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 12, 2024

Therapeutic potential of GNRHR analogs and SRC/FAK inhibitors to counteract tumor growth and metastasis in breast cancer.

Therapeutic potential of GNRHR analogs and SRC/FAK inhibitors to counteract tumor growth and metastasis in breast cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 21, 2024

The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer.

The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer.

Journal: Future oncology (London, England)
Published: November 18, 2024

KNDy Neurons and the Control of the Gonadotropic Axis in the Midgestation Fetal Sheep.

KNDy Neurons and the Control of the Gonadotropic Axis in the Midgestation Fetal Sheep.

Journal: Endocrinology
Published: November 18, 2024

Comparing the risk of cardiovascular disease between degarelix and gonadotropin-releasing hormone agonists:a systematic review and meta-analysis.

Comparing the risk of cardiovascular disease between degarelix and gonadotropin-releasing hormone agonists:a systematic review and meta-analysis.

Journal: Frontiers in oncology
Published: November 06, 2024
Showing 1-12 of 339

Last Updated: 10/31/2025